Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11667920
Methods for treating brain injury
granted -
US 11668704
Degradation preventing means for immunoassay reagent containing insoluble carrier particles
granted -
US 11667702
Stable aqueous formulations of aflibercept
granted -
US 11667911
Use of exonucleases to improve CRISPR/CAS-mediated genome editing
granted -
US 11670409
Method and apparatus for providing a pharmacokinetic drug dosing regiment
granted -
US 11667692
T cell receptors recognizing HLA-CW8 restricted mutated KRAS
granted -
US 11666612
Network-based microbial compositions and methods
granted -
US 11666661
Methods and compounds for targeted autophagy
granted -
US 11666536
Extended release compositions comprising pyridostigmine
granted -
US 11666557
Triazolone compounds and uses thereof
granted -
US 11667900
Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication
granted -
US 11666562
Ilaprazole for inhibiting the release of enveloped viruses from cells
granted -
US 11666637
Insulin-loaded metal-organic frameworks
granted -
US 11667687
Masked activatable interferon constructs
granted -
US 11666609
Methods of treating dog urinary tract infections
granted -
US 11666645
CD200 inhibitors and methods of use thereof
granted -
US 11666606
Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases
granted -
US 11667596
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11667611
Compositions and methods for inhibition of the JAK pathway
granted -
US 11666658
Rifamycin analogs and antibody-drug conjugates thereof
granted -
US 11667643
RIP1K inhibitors
granted -
US 11666574
Combination therapy involving diaryl macrocyclic compounds
granted -
US 11667683
Articles comprising a silk polypeptide for antigen delivery
granted -
US 11667637
Fused imidazo-piperidine JAK inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.